Skip to main content
. 2019 Nov;7(22):660. doi: 10.21037/atm.2019.10.75

Table 1. Clinical characteristics of patients grouped by 90-day mortality.

Characteristics All patients (N=77) 90-day survival (n=61) 90-day mortality (n=16) P value
Gender (male), n (%) 57 (74.0) 44 (72.1) 13 (81.2) 0.54
Age (years) 52 [40–59] 51 [38–59] 55 [49.25–61.5] 0.38
Comorbidities
   Diabetes mellitus, n (%) 9 (11.7) 5 (8.2) 4 (25.0) 0.08
   Hypertension, n (%) 57 (74.0) 45 (73.8) 12 (75.0) 1.00
Immunosuppression regimens before admission
   CsA + MMF + Pred, n (%) 32 (41.6) 25 (41.0) 7 (43.8) 1.00
   TAC + MMF + Pred, n (%) 39 (50.6) 31 (50.8) 8 (50.0) 1.00
   Rapa + MMF + Pred, n (%) 6 (7.8) 5 (8.2) 1 (6.3) 1.00
Median time from transplantation to ICU admission, months 8 [3–54] 8 [3–54.5] 5.5 [2.25–45.5] 0.47
Median time from fever onset to hospital admission, days 6 [3–7] 6 [3–7] 5.5 [1.8–7.3] 0.55
Median time from fever onset to ICU admission, days 7 [4–11] 7 [4–11] 8.5 [4–15.3] 0.58
Acute rejection history, n (%) 13 (16.9) 9 (14.75) 4 (25.0) 0.45
APACHE II score at ICU admission 12 [9–16] 11 [9–14] 17.5 [14–26] <0.01
PSI score at ICU admission 114 [99–134] 110 [98.5–128.5] 131 [102.75–155] 0.07
CURB-65 score at ICU admission 2 [2–3] 2 [2–2] 2.5 [2–3] 0.05
PaO2/FiO2 ratio (mmHg) at ICU admission 197 [131–264] 213 [150–274] 127 [103–203] <0.01
LDH (U/L)
   LDHday 1 (U/L) 360 [278–465] 334 [265–432] 440 [362–1,055] <0.001
   LDHday 3 (U/L) 334 [241–464.5] 290 [223–387.5] 522.5 [457.5–1,058.5] <0.001
   LDHc (%) −4.71 [−21.09–7.66] −10.79 [−24.36–2.83] 18.02 [6.59–42.14] <0.001
Outcome
   Median length of ICU stay, days 7 [4–13] 6 [3.5–10.5] 16.5 [5.5–30] 0.01
   Median length of hospital stay, days 23 [14.5–31] 21 [13–29] 33 [20–46] 0.04
   ICU mortality, n (%) 14 (18.2) 0 (0) 14 (87.5) <0.01
   Hospital mortality, n (%) 16 (20.8) 0 (0) 16 (100.0) <0.01

Values are median [interquartile range (IQR)] for continuous variables and percentages for categorical variables. The baseline immunosuppressive regimens included: CsA, cyclosporine A; TAC, tacrolimus; MMF, mycophenolate mofetil; Rapa, rapamycin; Pred, prednisone; APACHE-II, Acute Physiology and Chronic Health Evaluation II; PSI, Pneumonia Severity Index; ALT, alanine aminotransferase; LDHday1, LDH level at ICU admission; LDHday3, LDH level on day 3; LDHc, LDH change from day 1 to day 3 [calculated using the following formula: LDHc (%) = (LDHday3 – LDHday1)/LDHday1 ×100%].